Vitiligo Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children between 4 and 12 years old who have been diagnosed with a fast-spreading type of vitiligo (called non-segmental vitiligo) that has been getting worse in the past 6 weeks
- Children whose vitiligo affects between 1% and 50% of their total body skin
- Children whose parent or legal guardian agrees to take part and signs a consent form
Who may not be able to join:
- Children whose vitiligo has been stable and is not currently spreading
- Children with certain other types of vitiligo, including segmental, mucosal, undetermined, or generalized vitiligo
- Children who have taken medicines that suppress the immune system in the past 4 weeks
- Children who are known to be allergic to tacrolimus, related drugs (called macrolides), or any ingredients in the study medication
- Children with serious health conditions affecting the liver or kidneys that would make taking the study medicine unsafe
- Children who are obese or have certain other health conditions, such as tuberculosis, active or ongoing infections, high blood pressure, or a heart condition they were born with
- Children whose doctors feel that taking part in the trial could put them at risk or affect how the trial runs (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhe Jian, Associate Professor, First Affiliated Hospital of Air Force Medical University
Phone: +862984775406
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of Participants Achieving VASI 50 Response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.